Next, we revealed that SEMA6A is required for the integrity of the HIF-2α-β-catenin signaling pathway in ccRCC, and the genetic deletion of SEMA6A resulted in impaired proliferation ability in ccRCC cells by repressing SEC62-dependent β-catenin stabilization and activation. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.